PDS Biotechnology's market cap is currently $53.12M. The company's EPS TTM is $-1.167; its P/E ratio is ―; PDS Biotechnology is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -57.33K	$ -49.08K	$ -246.39K	$ -176.29K	$ -98.41K
Operating Income	$ -43.05M	$ -41.67M	$ -21.44M	$ -14.90M	$ -21.03M
EBITDA	$ -40.08M	$ -41.62M	$ -21.19M	$ -14.67M	$ -7.25M
Net Income	$ -42.94M	$ -40.85M	$ -16.92M	$ -14.85M	$ -7.00M
Balance Sheet
Cash & Short-Term Investments	$ 56.56M	$ 73.82M	$ 65.24M	$ 28.84M	$ 12.16M
Total Assets	$ 59.39M	$ 77.01M	$ 67.20M	$ 30.89M	$ 14.49M
Total Debt	$ 23.85M	$ 23.47M	$ 490.35K	$ 610.26K	$ 0.00
Net Debt	$ -32.71M	$ -50.35M	$ -64.75M	$ -28.23M	$ -12.16M
Total Liabilities	$ 33.26M	$ 33.01M	$ 3.99M	$ 3.76M	$ 2.79M
Stockholders' Equity	$ 26.13M	$ 44.00M	$ 63.21M	$ 27.13M	$ 11.70M
Cash Flow
Free Cash Flow	$ -33.64M	$ -25.71M	$ -12.49M	$ -13.15M	$ -18.07M
Operating Cash Flow	$ -33.64M	$ -25.71M	$ -12.49M	$ -13.15M	$ -18.07M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 29.38M
Financing Cash Flow	$ 16.38M	$ 34.29M	$ 48.89M	$ 29.83M	$ 750.00K

Currency in USD

PDS Biotechnology Earnings and Revenue History

Income Statement >

PDS Biotechnology Debt to Assets

Balance Sheet >

PDS Biotechnology Cash Flow

Cash Flow >

PDS Biotechnology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing